Together, these data demonstrate LAMC2 as an oncogenic player in iCCA by promoting EGFR translation and an indicator to identify iCCA patients who may benefit from available EGFR‐targeted TKIs therapies. The gene discussed is EGFR; the disease is infantile convulsions and choreoathetosis.